Concierge MedTravel logo for Medical Travel for prostate cancer and prostate cancer treatment and diagnosis
English French Italian Simplified Chinese Spanish

Click a flag to convert to a different language

Concierge MedTravel Image of an older couple – Medical Travel

News

 "EDAP's Ablatherm-HIFU Recognized as the Only HIFU Robotic Option At Global Urology Meeting EDAP Technology Added Alongside Robotic Devices for Prostate Cancer" - UroToday - November 9, 2007 

EDAP Launches Ablatherm-HIFU RPP Service At First South African Site:
Financial News - Yahoo! Finance
 (November 8, 2007)

Ablatherm-HIFU Adoption Growing Across Europe (May 17, 2007)

British Journal of Urology Demonstrates Ablatherm Success for Late Stage Prostate Cancer Therapy (February 5, 2007)

DISCLAIMER: This information is provided for informational purposes only.  Ablatherm ® HIFU is a non-FDA approved treatment that is in clinical trials in the U.S.  Ablatherm HIFU has been approved by and is being performed in certain countries other than the U.S.  For answers to your medical questions, you should consult your urologist.